Publications

(2022). CSF sphingomyelin metabolites in Alzheimer's disease, neurodegeneration, and neuroinflammation. medRxiv.

PDF DOI

(2021). Large-scale proteome analysis of CSF implicates altered glucose metabolism in Alzheimer's disease. medRxiv.

PDF DOI

(2021). Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer's disease diagnosis in a case-control analysis. medRxiv.

PDF DOI

(2021). Impact of a Rheumatology Clinic Protocol on Tobacco Cessation Quit Line Referrals. Arthritis Care & Research.

DOI

(2021). Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease. Proteomics. Clinical Applications.

DOI

(2021). Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations. Communications Biology.

PDF DOI

(2018). Connecting Rheumatology Patients to Primary Care for High Blood Pressure: Specialty clinic protocol improves follow-up and population blood pressures. Arthritis Care & Research.

DOI

(2018). RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes. Pharmacology Research & Perspectives.

PDF DOI

(2018). Bridging clinical researcher perceptions and health IT realities: A case study of stakeholder creep. International Journal of Medical Informatics.

PDF DOI

(2017). Rheumatologists Modestly More Likely to Counsel Smokers in Visits Without Rheumatoid Arthritis Control: An Observational Study. JCR: Journal of Clinical Rheumatology.

PDF DOI

(2017). Quit Connect Health Toolkit. University of Wisconsin-Madison School of Medicine and Public Health, UW Center for Tobacco Research and Intervention, and UW Health.

PDF